A COPD Quality Improvement Program（QIP）

Launched by SHENZHEN PEOPLE'S HOSPITAL · Nov 27, 2022

Keywords

ClinConnect Summary

The COPD Quality Improvement Program (QIP) is a study aimed at improving the care of patients with Chronic Obstructive Pulmonary Disease (COPD) in China. The program focuses on creating and following quality standards for managing COPD, which includes better ways to diagnose the condition, assess patients, and provide appropriate treatments and follow-up care. By standardizing how COPD is managed, the goal is to help patients receive timely and effective care, which can lead to better health outcomes.

To participate in this trial, you need to be diagnosed with COPD, be at least 40 years old, and have experienced two moderate or one severe flare-up of your symptoms in the past year. You also need to be able to understand and sign a consent form to join. If you're eligible, you can expect to be part of a program that aims to improve your care and management of COPD, making it easier for you to get the right treatments and support you need.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosed with COPD
• • 2. Aged 40 years or older
• • 3. CAT≥10
• • 4. With exacerbation history：
• • 1. at least 2 moderate or 1 severe exacerbation in the previous year
• • 2. or 1 moderate exacerbation in the previous year with FEV1 \<50% predicted value at baseline;
• • 5. Must able to sign the informed consent form
• Exclusion Criteria:
• • 1. Patients on triple therapy at baseline with a LAMA, LABA, and inhaled corticosteroid (ICS) combination (Including open triple and fix-dose triple)
• • 2. Significant diseases or conditions other than COPD, which, in the opinion of the Investigator, may put the subject at risk because of participation in the study or may influence either the results of the study or the subject's ability to participate in the study
• • 3. Patients who are currently involved in any other interventional studies

Trial Officials